Migratory langerhans cells in mouse lymph nodes in steady state and inflammation

Journal of Investigative Dermatology

Volumn 125, Issue 1, 2005, Pages 116-125

  Stoitzner, Patrizia ^a,c   Tripp, Christoph H ^a   Douillard, Patrice ^b   Saeland, Sem ^b,c   Romani, Nikolaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

Cell surface molecules; Cytokines; Dendritic cells; Inflammation; Skin; Steady state

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNIZATION; INFLAMMATION; LANGERHANS CELL; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 22144484148     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23757.x     Document Type: Article

References (42)

1. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2:725-731, 2001
2. Barnden MJ, Allison J, Heath WR, Carbone FR: Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34-40, 1998
3. + T cell tolerance. J Exp Med 196:1627-1638, 2002
4. Curtsinger JM, Lins DC, Mescher MF: Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function. J Exp Med 197:1141-1151, 2003
5. Freeman GJ, Long AJ, Iwai Y, et al: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027-1034, 2000
6. Geissmann F, Dieu-Nosjean MC, Dezutter C, et al: Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 196:417-430, 2002
7. Hawiger D, Inaba K, Dorsett Y, et al: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769-779, 2001
8. Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47-64, 2001
9. Hemmi H, Yoshino M, Yamazaki H, et al: Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int Immunol 13:695-704, 2001
10. Henri S, Vremec D, Kamath A, et al: The dendritic cell populations of mouse lymph nodes. J Immunol 167:741-748, 2001
11. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keeffe M: Differential production of IL-12, IFN-α, and IFN-gamma by mouse dendritic cell subsets. J Immunol 166:5448-5455, 2001
12. Iwasaki A, Kelsall BL: Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 190:229-239, 1999
13. Kahlon R, Hu YX, Orteu CH, Kifayet A, Trudeau JD, Tan RS, Dutz JP: Optimization of epicutaneous immunization for the induction of CTL. Vaccine 21: 2890-2899, 2003
14. Latchman Y, Wood CR, Chernova T, et al: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2:261-268, 2001
15. Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, Sharpe AH: Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33:2706-2716, 2003
16. Lyons AB: Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243:147-154, 2000
17. Mayerova D, Parke EA, Bursch LS, Odumade OA, Hogquist KA: Langerhans cells activate naïve self-antigen specific CD8 T cells in the steady state. Immunity 21:391-400, 2004
18. McLellan AD, Kapp M, Eggert A, et al: Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 99:2084-2093, 2002
19. McLellan AD, Starling GC, Hart DNJ: Isolation of human blood dendritic cells by discontinuous Nycodenz gradient centrifugation. J Immunol Methods 184:81-89, 1995
20. Menges M, Rössner S, Voigtländer C, et al: Repetitive injections of dendritic cells matured with tumor necrosis factor a induce antigen-specific protection of mice from autoimmunity. J Exp Med 195:15-21, 2002
21. Müller G, Saloga J, Germann T, Schuler G, Knop J, Enk AH: IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol 155:4661-4668, 1995
22. Ohl L, Mohaupt M, Czeloth N, et al: CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279-288, 2004
23. + T cell tolerance. Immunity 18:713-720, 2003
24. Randolph GJ: Commentary - is maturation required for Langerhans cell migration? J Exp Med 196:413-416, 2002
25. Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P: Langerhans cells-dendritic cells of the epidermis. APMIS 111:725-740, 2003
26. Ruedl C, Koebel P, Bachmann M, Hess M, Karjalainen K: Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol 165:4910-4916, 2000
27. Ruedl C, Koebel P, Karjalainen K: In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J Immunol 166:7178-7182, 2001
28. Salomon B, Cohen JL, Masurier C, Klatzmann D: Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol 160:708-717, 1998
29. Seo N, Tokura Y, Nishijima T, Hashizume H, Furukawa F, Takigawa M: Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci USA 97:371-376, 2000
30. + T cells into keratin-14-ovalbumin transgenic mice. J Invest Dermatol 123: 109-115, 2004
31. Shortman K, Heath WR: Immunity or tolerance? That is the question for dendritic cells. Nat Immunol 2:988-989, 2001
32. Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711, 2003
33. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-358, 2002
34. Stoitzner P, Holzmann S, McLellan AD, et al: Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 120:266-274, 2003
35. Streilein JW: Antigen-presenting cells in the induction of contact hypersensitivity in mice: Evidence that Langerhans cells are sufficient but not required. J Invest Dermatol 93:443-448, 1989
36. + cells are capable of initiating delayed type hypersensitivity responses. J Invest Dermatol 94:267-272, 1990
37. Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, et al: Identification of mouse Langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 168:782-792, 2002
38. Valladeau J, Ravel O, Dezutter-Dambuyant C, et al: Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71-81, 2000
39. Weinlich G, Heine M, Stössel H, et al: Entry into afferent lymphatics and maturation in situ of migrating cutaneous dendritic cells. J Invest Dermatol 110:441-448, 1998
40. Wilson NS, El Sukkari D, Belz GT, et al: Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187-2194, 2003
41. Wilson NS, Villadangos JA: Lymphoid organ dendritic cells: Beyond the Langerhans cells paradigm. Immunol Cell Biol 82:91-98, 2004
42. Witsch EJ, Peiser M, Hutloff A, et al: ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Eur J Immunol 32:2680-2686, 2002